Oncoclínicas Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
2,137
- Stock Symbol
-
ONCO3
- Investments
-
24
- Share Price
-
$0.14
- (As of Friday Closing)
Oncoclínicas General Information
Description
Oncoclinicas Do Brasil Servicos Medicos SA is engaged in the management and administration of oncological services. It has specialists in the areas of oncology, radiotherapy, hematology, and bone marrow transplantation, complementary care. The Group operates solely in the healthcare services segment, with an emphasis on oncology.
Contact Information
Website
www.grupooncoclinicas.comCorporate Office
- Avenida Presidente Juscelino Kubitschek
- Nº 510, 2nd floor, Vila Nova Conceição
- Sao Paulo, 04543-906
- Brazil
Corporate Office
- Avenida Presidente Juscelino Kubitschek
- Nº 510, 2nd floor, Vila Nova Conceição
- Sao Paulo, 04543-906
- Brazil
Oncoclínicas Timeline
Oncoclínicas Stock Performance
As of 13-Nov-2026, Oncoclínicas’s stock price is $0.14. Its current market cap is $162M with 1.13B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.14 | $0.16 | $0.10 - $0.58 | $162M | 1.13B | 17.3M | -$0.97 |
Oncoclínicas Financials Summary
As of 30-Jun-2026, Oncoclínicas has a trailing 12-month revenue of $942M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,000,905 | 1,372,149 | 883,137 | 2,084,407 |
| Revenue | 942,185 | 1,025,491 | 1,155,658 | 1,098,159 |
| EBITDA | (571,851) | (400,610) | 42,045 | 219,369 |
| Net Income | (798,657) | (647,487) | (119,921) | 44,740 |
| Total Assets | 1,272,280 | 1,301,379 | 1,812,411 | 1,891,773 |
| Total Debt | 735,327 | 693,316 | 886,343 | 938,654 |
Oncoclínicas Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Oncoclínicas Signals
Oncoclínicas Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Oncoclínicas Investments & Acquisitions (24)
Oncoclínicas’s most recent deal was a Merger/Acquisition with Cettro. The deal was made on 01-Feb-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cettro | 01-Feb-2025 | Merger/Acquisition | Hospitals/Inpatient Services | ||
| Joint Venture (Oncoclínicas / Al Faisaliah Group) | 06-Aug-2024 | Joint Venture | Clinics/Outpatient Services | ||
| Joint Venture (Oncological Medical Services) | 07-Jun-2023 | Joint Venture | Clinics/Outpatient Services | ||
| Centro De Excelência Oncológica | 18-May-2023 | Buyout/LBO | Clinics/Outpatient Services | ||
| Cardiomobile Cardiomovel | 07-Feb-2023 | Buyout/LBO | Clinics/Outpatient Services |
Oncoclínicas ESG
Risk Overview
Risk Rating
Updated December, 31, 2023
25.16 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,766
Rank
Percentile
Healthcare
Industry
of 581
Rank
Percentile
Medical Services
Subindustry
of 100
Rank
Percentile
Oncoclínicas Exits (2)
Oncoclínicas’s most recent exit was on 21-Mar-2022 from Medsir. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Medsir | 21-Mar-2022 | Completed |
|
||
| Hospital Marcos Moraes | 19-Aug-2020 | Merger/Acquisition | Completed |
|
Oncoclínicas Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Boston Lighthouse Innovations | Cambridge, MA | 2017 | |
| Hospital Vila da Serra | Nova Lima, Brazil | 1999 | |
| Cemise | Aracaju, Brazil | 1988 | |
| Unidade de Oncologia Clínica e Pediátrica | Sao Paulo, Brazil | 1987 |
Oncoclínicas FAQs
-
When was Oncoclínicas founded?
Oncoclínicas was founded in 2010.
-
Where is Oncoclínicas headquartered?
Oncoclínicas is headquartered in Sao Paulo, Brazil.
-
What is the size of Oncoclínicas?
Oncoclínicas has 2,137 total employees.
-
What industry is Oncoclínicas in?
Oncoclínicas’s primary industry is Hospitals/Inpatient Services.
-
Is Oncoclínicas a private or public company?
Oncoclínicas is a Public company.
-
What is Oncoclínicas’s stock symbol?
The ticker symbol for Oncoclínicas is ONCO3.
-
What is the current stock price of Oncoclínicas?
As of 13-Nov-2026 the stock price of Oncoclínicas is $0.14.
-
What is the current market cap of Oncoclínicas?
The current market capitalization of Oncoclínicas is $162M.
-
What is Oncoclínicas’s current revenue?
The trailing twelve month revenue for Oncoclínicas is $942M.
-
What is Oncoclínicas’s annual earnings per share (EPS)?
Oncoclínicas’s EPS for 12 months was -$0.97.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process